10x Genomics, Inc. — Director's Dealing 2020

Jan 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-01-10

Reporting Person: Saxonov Serge (Director, Chief Executive Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-10	Stock Option (right to buy)	$1.20	A	150000	Acquired	2027-10-18	Class A Common Stock (150000)	Direct

Footnotes

F1: On January 10, 2020, the Compensation Committee of the Board of Directors of the Issuer determined that certain performance targets had been achieved pertaining to a 150,000 share option granted to the Reporting Person on October 18, 2017. The option vests as to one-thirty-sixth of the shares on January 1, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.